Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we will assume that you are happy to receive all cookies and you will not see this message again. Click 'Find out more' for information on how to change your cookie settings.

Research groups

Ashling Holland


Postdoctoral Research Scientist

I am a postdoctoral researcher in Professor Matthew Wood’s lab working on translational research for neuromuscular disorders, more specifically on Myotonic Dystrophy type 1 (DM1).

I completed my PhD on proteomic analysis of animal models of neuromuscluar disorders, including Duchenne muscular dystrophy (DMD) and amyotrophic lateral sclerosis (ALS), in Professor Kay Ohlendieck’s Muscle Biology lab at Maynooth University, Ireland (2011-2015). My first postdoctoral research project centred on defining the roles and mechanisms of action of Pellino proteins in immunity and inflammatory diseases in Professor Paul Moynagh’s Molecular Immunology lab at Maynooth University, Ireland (2015-2017). 

My current research focuses on the pre-clinical development of a gene therapy for DM1 using cell penetrating peptides conjugated to phosphorodiamidate morpholino oligonucleotides (PMO). Our aim is to develop a therapy that provides an efficient and safe delivery of next generation antisense oligonucleotides targeting the toxic CTG repeat expansion sequences specific for the treatment of DM1.

My research interests also include exploring the DM1 proteome and identifying novel pathological pathways that contribute to the pathophysiology of DM1 and to investigate novel therapeutic strategies in order to correct the defects.